Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Accumulation of misfolded proteins leads to many neurodegenerative diseases that can be treated by lowering or removing mutant proteins. Huntington disease (HD) is characterized by the accumulation of ubiquitinated mutant HTT (huntingtin) in the central nervous system. Ubiquitination of the misfolded proteins, a common feature of the neurodegenerative diseases, is mediated by the different lysine residues on ubiquitin. We previously discovered that the age-dependent increase of UBE2N (ubiquitin conjugating enzyme E2 N) exacerbated the accumulation of misfolded HTT and amyloid proteins, accompanied by the elevation of K63 ubiquitination. Pharmacological inhibition of UBE2N could ameliorate the amyloid deposition. However, the effect of UBE2N suppression on HTT aggregate clearance has remained unknown. In the current work, we demonstrate that selectively suppressing UBE2N, with antisense oligonucleotides or small-molecular inhibitors, increased removal of HTT aggregates by proteasome degradation in the striatum of HD knock-in mice. We also identified two novel ubiquitin specific peptidases, USP29 and USP49, that participated in the clearance of HTT aggregates, via accelerating K48-mediated ubiquitin-proteasome function. Our findings provide a potential pharmacological approach to treat neurodegeneration caused by mutant HTT.Abbreviation: AD: Alzheimer disease; ALP: autophagy-lysosomal pathway; AMC: 7-Amino-4-Methylcoumarin; ASO: antisense oligonucleotide; Aβ: amyloid β; BafA1: bafilomycin A1; DEG: differentially expressed gene; DMSO: dimethyl sulfoxide; E2: ubiquitin-conjugating; E3: ubiquitin-ligating; EGFP: enhanced green fluorescent protein; HD: Huntington disease; HTT: huntingtin; KI: knock-in; SDS: sodium dodecyl sulfate; UPS: ubiquitin-proteasome system; UBE2N: ubiquitin conjugating enzyme E2 N; USP: ubiquitin-specific peptidase.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice
- Date Crossref
- 20/08/2025
- Éditeur
- Informa UK Limited
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Jinan University State Key Laboratory of Bioactive Molecules and Druggability Assessment pays non établi dans la noticeUniversité ou école supérieure
-
Lingang Laboratory pays non établi dans la noticeStructure de recherche
State Key Laboratory of Bioactive Molecules and Druggability Assessment — Jinan University et Lingang Laboratory.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.